← All organizations

Saptalis Pharmaceuticals

For profit

Also known as: Saptalis Pharmaceuticals | Saptalis Pharmaceuticals LLC | SAPTALIS PHARMACEUTICALS, LLC | SAPTALIS PHARMS

Highest phase reached

Phase 3

First clinical trial

Apr 10, 2018

First marketed drug

Jun 1, 2015

Last known activity

Aug 31, 2025

Timeline

1960s

  1. Jun 23, 1961

    urea— NDA Secondary Org

2010s

  1. Jun 1, 2015

    Saptalis Pharmaceuticals— Founded

  2. Aug 23, 2019

    azelastine— Marketing Organization

Drugs by trial phase (2 distinct, 2 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (28)

Recent trials (2)

Details

Founded
Hauppage, NY, US Jun 1, 2015
Last known activity
Aug 31, 2025